AusAm Biotechnologies Introduces New AccuChrom Chromatography Technology
10/19/2005 5:11:30 PM
AusAm Biotechnologies, Inc. today announced that its AccuChrom chromatography technology will be introduced at this week's American Association of Clinical Chemistry Annual Meeting (AACC) in Los Angeles. The High Performance Liquid Chromatography (HPLC) equipment is specifically designed to work with the FDA-cleared Accumin total intact albumin test to measure urinary albumin, a critical indicator of potential kidney disease. AusAm can now provide a complete tool set--reagents, methodology and platform--to hospitals and laboratories implementing the first direct method to detect albumin in urine.
comments powered by